tiprankstipranks
Advertisement
Advertisement
Bio-Rad Laboratories Stockholders Approve Directors and Governance Items
PremiumCompany AnnouncementsBio-Rad Laboratories Stockholders Approve Directors and Governance Items
8d ago
Bio-Rad downgraded to Neutral from Buy at Citi
Premium
The Fly
Bio-Rad downgraded to Neutral from Buy at Citi
26d ago
Bio-Rad downgraded to Neutral from Buy at Citi
Premium
The Fly
Bio-Rad downgraded to Neutral from Buy at Citi
26d ago
Bio-Rad Laboratories Posts Mixed Q4 2025 Financial Results
PremiumCompany AnnouncementsBio-Rad Laboratories Posts Mixed Q4 2025 Financial Results
3M ago
Bio-Rad reports Q4 adjusted EPS $2.51, consensus $2.70
Premium
The Fly
Bio-Rad reports Q4 adjusted EPS $2.51, consensus $2.70
3M ago
Bio-Rad sees FY26 currency neutral revenue growth 0.5%-1.5%
Premium
The Fly
Bio-Rad sees FY26 currency neutral revenue growth 0.5%-1.5%
3M ago
Bio-Rad price target raised to $340 from $265 at Wells Fargo
PremiumThe FlyBio-Rad price target raised to $340 from $265 at Wells Fargo
6M ago
Bio-Rad Laboratories Reports Stable Q3 2025 Results
Premium
Company Announcements
Bio-Rad Laboratories Reports Stable Q3 2025 Results
6M ago
Bio-Rad Reports Q3 2025 Financial Results Amid Challenges
Premium
Company Announcements
Bio-Rad Reports Q3 2025 Financial Results Amid Challenges
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100